The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant docetaxel and cyclophosphamide (DC) with prophylactic growth colony stimulating factor (GCSF) on days 8 and 12 in breast cancer patients: A retrospective analysis.
Rinat Yerushalmi
No relevant relationships to disclose
Salomon M. Stemmer
No relevant relationships to disclose
Daniel Hendler
No relevant relationships to disclose
Victoria Neiman
No relevant relationships to disclose
Noa Beatrice Ciuraru
No relevant relationships to disclose
Luisa Bonilla
No relevant relationships to disclose
Irit Ben-Aharon
No relevant relationships to disclose
Limor Amit
No relevant relationships to disclose
Tal Granot
No relevant relationships to disclose
Alona Zer
No relevant relationships to disclose
Aaron Sulkes
No relevant relationships to disclose
Shulamith Rizel
No relevant relationships to disclose